Haemophilus influenzae type a infection and its prevention.
作者信息
Jin Zhigang, Romero-Steiner Sandra, Carlone George M, Robbins John B, Schneerson Rachel
机构信息
National Institutes of Health, Building 31, Room 2A29, Bethesda, MD 20892, USA.
出版信息
Infect Immun. 2007 Jun;75(6):2650-4. doi: 10.1128/IAI.01774-06. Epub 2007 Mar 12.
Abstract
摘要
相似文献
1
Haemophilus influenzae type a infection and its prevention.
Infect Immun. 2007 Jun;75(6):2650-4. doi: 10.1128/IAI.01774-06. Epub 2007 Mar 12.
2
Is Haemophilus influenzae type b disease finished?
Adv Exp Med Biol. 2004;549:221-9. doi: 10.1007/978-1-4419-8993-2_29.
3
[Polysaccharide vaccines against Haemophilus influenzae type B].
Przegl Epidemiol. 1994;48(1-2):39-44.
4
Haemophilus influenzae type B disease control using PENTACEL, Canada, 1998-1999.
Can Commun Dis Rep. 2000 Jun 1;26(11):93-6.
5
[Progress toward molecular determinants of the pathogenesis of disease due to nontypeable Haemophilus influenzae].
Zhongguo Yi Miao He Mian Yi. 2009 Apr;15(2):174-9.
6
Continuing surveillance of invasive disease in northwestern Ontario emphasizes the importance of serotype a and non-typeable strains as causes of serious disease: a Canadian Immunization Research Network (CIRN) Study.
Can J Microbiol. 2019 Nov;65(11):805-813. doi: 10.1139/cjm-2019-0210. Epub 2019 Jun 26.
7
[Vaccination against Haemophilus influenzae B].
Orv Hetil. 1996 Nov 10;137(45):2547-8.
8
The launch of an infant Haemophilus influenzae type B immunization programme in Iceland.
Arctic Med Res. 1991;Suppl:341-3.
9
[Hemophilus influenzae infection and their prevention by vaccination].
Kinderarztl Prax. 1993 Aug;61(6):189-91.
10
Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infections.
Adv Exp Med Biol. 1998;435:237-43. doi: 10.1007/978-1-4615-5383-0_22.
引用本文的文献
1
Synthesis and Immunogenicity of Pseudo-Oligosaccharides Structurally Related to Repeating Units of Capsular Phosphoglycans of Human Pathogens.
Molecules. 2025 Jul 22;30(15):3068. doi: 10.3390/molecules30153068.
2
An exploration of the role of trust and rapport in enhancing vaccine uptake among Anishinaabe in rural northern Ontario.
PLoS One. 2024 Dec 5;19(12):e0308876. doi: 10.1371/journal.pone.0308876. eCollection 2024.
3
Haemophilus influenzae serotype a meningitis in an elderly patient: A case report and literature review.
IDCases. 2024 Oct 15;38:e02094. doi: 10.1016/j.idcr.2024.e02094. eCollection 2024.
4
Synthesis of Pseudooligosaccharides Related to the Capsular Phosphoglycan of Type .
Molecules. 2023 Jul 27;28(15):5688. doi: 10.3390/molecules28155688.
5
Ocular Bacterial Infections: A Ten-Year Survey and Review of Causative Organisms Based on the Oklahoma Experience.
Microorganisms. 2023 Jul 13;11(7):1802. doi: 10.3390/microorganisms11071802.
6
Epidemiology of invasive serotype a disease in the North American , 2006-2017.
Int J Circumpolar Health. 2022 Dec;81(1):2150382. doi: 10.1080/22423982.2022.2150382.
7
Glycoconjugate Vaccines for Prevention of Type b Diseases.
Russ J Bioorg Chem. 2021;47(1):26-52. doi: 10.1134/S1068162021010106. Epub 2021 Mar 20.
8
Complete Genome Sequence of a Japanese Clinical Isolate of Haemophilus influenzae Type a Strain TAMBA230.
Microbiol Resour Announc. 2020 Nov 25;9(48):e01069-20. doi: 10.1128/MRA.01069-20.
9
Case report of congenital asplenia presenting with Haemophilus influenzae type a (Hia) sepsis: an emerging pediatric infection in Minnesota.
BMC Infect Dis. 2019 Nov 8;19(1):947. doi: 10.1186/s12879-019-4572-4.
10
Potential targets for next generation antimicrobial glycoconjugate vaccines.
FEMS Microbiol Rev. 2018 May 1;42(3):388-423. doi: 10.1093/femsre/fuy011.
本文引用的文献
1
THE ACTION OF TYPE-SPECIFIC HEMOPHILUS INFLUENZAE ANTISERUM.
J Exp Med. 1933 Nov 30;58(6):683-706. doi: 10.1084/jem.58.6.683.
2
VARIATION AND TYPE SPECIFICITY IN THE BACTERIAL SPECIES HEMOPHILUS INFLUENZAE.
J Exp Med. 1931 Mar 31;53(4):471-92. doi: 10.1084/jem.53.4.471.
3
Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa.
Bull World Health Organ. 2006 Oct;84(10):811-8. doi: 10.2471/blt.06.030361.
4
WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record.
Wkly Epidemiol Rec. 2006 Nov 24;81(47):445-52.
5
Assessment of carriage of Haemophilus influenzae type a after a case of invasive disease.
Clin Infect Dis. 2006 Aug 1;43(3):386-7. doi: 10.1086/505602.
6
Invasive Haemophilus influenzae in Manitoba, Canada, in the postvaccination era.
J Clin Microbiol. 2006 Apr;44(4):1530-5. doi: 10.1128/JCM.44.4.1530-1535.2006.
7
Invasive infections with Haemophilus influenzae serotype a containing an IS1016-bexA partial deletion: possible association with virulence.
Clin Infect Dis. 2005 Dec 1;41(11):e97-103. doi: 10.1086/498028. Epub 2005 Oct 25.
8
Occurrence of Haemophilus influenzae strains in three Brazilian states since the introduction of a conjugate Haemophilus influenzae type b vaccine.
Braz J Med Biol Res. 2005 May;38(5):777-81. doi: 10.1590/s0100-879x2005000500016. Epub 2005 May 25.
9
Outbreak of invasive Haemophilus influenzae serotype a disease.
Pediatr Infect Dis J. 2005 May;24(5):453-6. doi: 10.1097/01.inf.0000160954.90881.29.
10
Epidemiology of invasive Haemophilus influenzae type A disease among Navajo and White Mountain Apache children, 1988-2003.
Clin Infect Dis. 2005 Mar 15;40(6):823-30. doi: 10.1086/428047. Epub 2005 Feb 18.
Zotero 插件